Marijuana stocks were broadly lower Thursday after MedMen revealed it's slashing executive pay amid widening losses.
Marijuana stocks were broadly lower Thursday after MedMen (OTC: MMNFF) revealed it's slashing executive pay amid widening losses. It comes as the FDA is set to hold its first public hearing on CBD, a nonintoxicating cannabis compound claimed to have therapeutic benefits.
Read more: Investor's Business Daily
